1-5 of 5
B Van Ness
Close
Sort by
Journal Articles

Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial

P Liu, T Leong, L Quam, D Billadeau, NE Kay, P Greipp, RA Kyle, MM Oken, B Van Ness
Journal: Blood
Blood (1996) 88 (7): 2699–2706.
https://doi.org/10.1182/blood.V88.7.2699.bloodjournal8872699
Published: 1996
Journal Articles

Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma

D Billadeau, B Van Ness, T Kimlinger, RA Kyle, TM Therneau, PR Greipp, TE Witzig
Journal: Blood
Blood (1996) 88 (1): 289–296.
https://doi.org/10.1182/blood.V88.1.289.289
Published: 1996
Journal Articles

Circulating CD19+ blood cell levels in myeloma. ECOG Myeloma Clinical Trials Laboratory Study Group [letter]

NE Kay, MM Oken, N Bone, RA Kyle, P Greipp, B Van Ness, T Leong
Journal: Blood
Blood (1995) 86 (10): 4000–4001.
https://doi.org/10.1182/blood.V86.10.4000.bloodjournal86104000
Published: 1995
Journal Articles

Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients

D Billadeau, L Quam, W Thomas, N Kay, P Greipp, R Kyle, MM Oken, B Van Ness
Journal: Blood
Blood (1992) 80 (7): 1818–1824.
https://doi.org/10.1182/blood.V80.7.1818.1818
Published: 1992
Journal Articles

Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: a technique for sequential quantitation of residual disease

D Billadeau, M Blackstadt, P Greipp, RA Kyle, MM Oken, N Kay, B Van Ness
Journal: Blood
Blood (1991) 78 (11): 3021–3029.
https://doi.org/10.1182/blood.V78.11.3021.3021
Published: 1991